SETTLEMENT AGREEMENTSettlement Agreement • November 22nd, 2021 • Adamis Pharmaceuticals Corp • Pharmaceutical preparations • Florida
Contract Type FiledNovember 22nd, 2021 Company Industry JurisdictionThis Settlement Agreement (“Agreement”) is entered into among Nephron Pharmaceuticals Corporation, Nephron S.C., Inc., and Nephron Sterile Compounding Center, LLC (“Nephron” or “Plaintiff’), and U.S. Compounding, Inc. (“U.S. Compounding”), Adamis Pharmaceuticals Corporation (“Adamis”), Jennifer Shelly Hulsey (“Hulsey”), and Jessica Ingrid Lane (“Lane”) (together hereinafter “Defendants”). Nephron and Defendants are collectively hereinafter referred to as the “Parties”.